- Home
- AOS vs EXAS Comparison
AOS vs EXAS Comparison
Compare AOS & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AOS
- EXAS
- Stock Information
- Founded
- AOS 1874
- EXAS 1995
- Country
- AOS United States
- EXAS United States
- Employees
- AOS N/A
- EXAS N/A
- Industry
- AOS Industrial Machinery/Components
- EXAS Medical Specialities
- Sector
- AOS Industrials
- EXAS Health Care
- Exchange
- AOS Nasdaq
- EXAS Nasdaq
- Market Cap
- AOS 9.9B
- EXAS 10.5B
- IPO Year
- AOS N/A
- EXAS N/A
- Fundamental
- Price
- AOS $71.81
- EXAS $51.74
- Analyst Decision
- AOS Buy
- EXAS Strong Buy
- Analyst Count
- AOS 7
- EXAS 16
- Target Price
- AOS $83.14
- EXAS $72.80
- AVG Volume (30 Days)
- AOS 1.1M
- EXAS 2.2M
- Earning Date
- AOS 01-30-2025
- EXAS 02-19-2025
- Dividend Yield
- AOS 1.90%
- EXAS N/A
- EPS Growth
- AOS 92.33
- EXAS N/A
- EPS
- AOS 3.79
- EXAS N/A
- Revenue
- AOS $3,893,800,000.00
- EXAS $2,692,328,000.00
- Revenue This Year
- AOS $1.15
- EXAS $11.81
- Revenue Next Year
- AOS $3.34
- EXAS $11.52
- P/E Ratio
- AOS $18.94
- EXAS N/A
- Revenue Growth
- AOS 2.45
- EXAS 11.91
- 52 Week Low
- AOS $67.17
- EXAS $40.62
- 52 Week High
- AOS $92.45
- EXAS $79.62
- Technical
- Relative Strength Index (RSI)
- AOS 57.79
- EXAS 35.28
- Support Level
- AOS $70.68
- EXAS $49.79
- Resistance Level
- AOS $73.09
- EXAS $60.88
- Average True Range (ATR)
- AOS 1.38
- EXAS 2.67
- MACD
- AOS 0.62
- EXAS -0.59
- Stochastic Oscillator
- AOS 78.38
- EXAS 17.58
About AOS A.O. Smith Corporation
A.O. Smith Corporation manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments, North America (75% of sales) and rest of world (25% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for both residential and commercial markets, with approximately 37% and 54% market share, respectively. Residential water heaters account for Most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered during the mid-1990s.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.